山东药玻(600529.SH)发布前三季度业绩，归母净利润5.42亿元，同比下降24.7%

Core Insights - Shandong Pharmaceutical Glass (600529.SH) reported a revenue of 3.401 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 11.10% [1] - The company's net profit attributable to shareholders was 542 million yuan, down 24.7% year-on-year [1] - The non-recurring net profit stood at 516 million yuan, reflecting a decrease of 25.13% compared to the previous year [1] - Basic earnings per share were reported at 0.8174 yuan [1]